Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA

This publication has 28 references indexed in Scilit:

• Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials
  Blood, 2008
• The use of Armored RNA as a multi-purpose internal control for RT-PCR
  Journal of Virological Methods, 2008
• A multiplex PCR for improved detection of typical and atypical BCR–ABL fusion transcripts
  Leukemia Research, 2008
• Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results
  Blood, 2006
• Molecular Monitoring of Chronic Myelogenous Leukemia
  The Journal of Molecular Diagnostics, 2006
• Properties of the Reverse Transcription Reaction in mRNA Quantification
  Clinical Chemistry, 2004
• Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia
  New England Journal of Medicine, 2003
• Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program
  Leukemia, 2003
• Estimate of standard deviation for a log‐transformed variable using arithmetic means and standard deviations
  Statistics in Medicine, 2003
• The Biology of Chronic Myeloid Leukemia
  New England Journal of Medicine, 1999